NCT07531667 is a NA clinical trial of Fresnel prism in Fresnel Prism, sponsored by Indonesia University.

Who is sponsoring NCT07531667?

NCT07531667 is sponsored by Indonesia University.

What drugs are being tested in NCT07531667?

Interventions in NCT07531667: Fresnel prism.

What condition does NCT07531667 study?

NCT07531667 studies Fresnel Prism.

Is NCT07531667 still recruiting?

NCT07531667 is currently completed. Last updated 15 April 2026.

Last reviewed 2026-04-15 · How we verify

NCT07531667

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fresnel Prism in Low Vision Patients With Homonymous Hemianopia Defect in Cipto Mangunkusumo Hospital

Completed NA Last updated 15 April 2026

What this trial tests

NA trial testing Fresnel prism in Fresnel Prism in 25 participants. Completed in 1 August 2022.

Timeline

1 May 2022

Primary endpoint
1 July 2022

1 August 2022

Quick facts

Lead sponsor	Indonesia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	1 May 2022
Primary completion	1 July 2022
Estimated completion	1 August 2022
Sites	1 location across Indonesia

Drugs / interventions tested

Fresnel prism

Conditions studied

Fresnel Prism — all drugs for Fresnel Prism →

Sponsor

Indonesia University

Who can join

18 and older, any sex, with Fresnel Prism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Homonymous hemianopia is a visual field defect that causes functional disabilities, such as decreased self-confidence, limited mobility, and increased risk of falls. Studies related to the effectiveness and comfort of Fresnel prisms, especially in the Indonesian population are limited. Objective: To evaluate the effectiveness and comfort level of Fresnel prisms in expanding visual field in an Indonesian patient population with homonymous hemianopia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Indonesia University trials

Trials by the same sponsor.

NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07531667 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indonesia University
Last refreshed: 15 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07531667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing